GUO Zhen-lang, SU Zhen-ning, WANG Zheng-fei, et al. Meta-analysis of Reflux Esophagitis Treated by Modified Banxia Xiexin Tang[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(24): 219-224.
DOI:
GUO Zhen-lang, SU Zhen-ning, WANG Zheng-fei, et al. Meta-analysis of Reflux Esophagitis Treated by Modified Banxia Xiexin Tang[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(24): 219-224. DOI: 10.13422/j.cnki.syfjx.2015240219.
Meta-analysis of Reflux Esophagitis Treated by Modified Banxia Xiexin Tang
Objective: To study the safety and efficacy of modified Banxia Xiexin Tang in treating reflux esophagitis(RE). Method: We searched Pubmed
The Cochrane Library
Embase
CNKI
CBM
VIP and Wanfang Data through computer for data June 20
2015.All of Randomized Controlled Trials(RCTs) of modified Banxia Xiexin Tang in treating reflux esophagitis were searched
and research literatures included in the RCTs were also traced. Two researchers independently conducted the strict quality evaluation and data extraction for the included studies on the basis of the Cochrane system assessor handbook 5.1
and made a Meta-analysis by using RevMan 5.3 software. Result: Totally 12 RCTs involving 914 patients were included into the study. The Meta-analysis results showed that compared with the pure application of western medicine
modified Banxia Xiexin Tang in treating reflux esophagitis can significantly improve the comprehensive clinical efficacy[OR=3.41
95%CI(2.22
5.23)
P<0.00001]
improve the efficacy under gastroscope[OR=1.58
95%CI(1.04
2.41)
P=0.03] and reduce the recurrence rate[OR=0.23
95%CI(0.14
0.40)
P<0.00001]
with statistical significant differences. In the Adverse reactions
one study showed follow-up reports that the treatment group showed no obvious adverse reaction
whereas the control group showed 14 different degree of adverse reactions
including 4 cases of nausea
7 cases of headache
2 cases of abdominal pain
1 case of soreness of waist
but all of them were tolerant to the drug until the end of the treatment
and the above adverse reactions were relieved with the continuous medication.Sensitivity analysis results showed a stable efficacy evaluation
asymmetric 'Funnel Plot' analysis
with the potential publication bias. Conclusion: Banxia Xiexin Tang in treating reflux esophagitis shows a superior comprehensive clinical efficacy to conventional western medicine
without any severe adverse effect. Therefore
more multicenter
randomized
double-blind trials with a large sample size are required to further verifythe efficacy and safety of Banxia Xiexin Tang in treating reflux esophagitis.
Efficacy and Safety of Modified Qingjin Huatantang Combined with Western Medicine in Treatment of Phlegm-heat: A Systematic Review and Meta-analysis
Dissipating Phlegm and Removing Blood Stasis for Treatment of Vascular Cognitive Impairment:A Meta-analysis of Randomized Controlled Trials
Meta Analysis on Traditional Chinese Medicine Tonic Class Prescriptions in Treatment of Amyotrophic Lateral Sclerosis
Meta-analysis on Traditional Chinese Medicine of Tonifying Kidney Combined with Western Medicine for Treatment of Senile Dementia
Related Author
WANG Lu
WANG Jiajia
LIU Jiamin
LI Jiansheng
WANG Hui
HAN Tao
ZHANG Ting
JING Heng
Related Institution
The First Clinical Medical School of Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province and Education Ministry of P.R. China/Henan Key Laboratory of Chinese Medicine for Respiratory Disease,Henan University of Chinese Medicine
Fangchenggang Municipal Hospital of Traditional Chinese Medicine
School of Basic Medical Sciences, Guangxi University of Chinese Medicine